lenalidomide,iberdomide,dexamethasone,daratumumab,bortezomib,carfilzomib
janssen,takeda,amgen,bms
nct02773030: phase 1/2: cc-220 monotherapy and in combination with treatments in ndmm / rrmm #mmsm #multiplemyeloma #ims2022 
Multiple Myeloma Education Platform for Myeloma Community